Comparison

KIF18A-IN-6 European Partner

Item no. HY-153065-1ea
Manufacturer MedChem Express
CASRN 2914879-10-8
Amount 1 ea
Category
Type Chemicals
Specific against other
Purity 98.56
Citations [1]COGAN, et al. SPIRO INDOLINE INHIBITORS OF KIF18A. Patent WO2023028564.
Smiles O=S(C1=CC(C(N2CC3(CCC4(CC4)CC3)C5=CC(NS(CC)(=O)=O)=CC=C52)=O)=CC=C1)(NC(C)(C)C)=O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
KIF18A-IN-6 (Compound 134) is an orally active KIF18A inhibitor with an IC50 of 0.016 μM against KIF18A microtubule-dependent ATPase activity[1].
StorageTemperature
-20°C, 3 years (Powder)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
559.74
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 125 mg/mL (ultrasonic)
Manufacturers Target
Microtubule/Tubulin
Pathway
Cell Cycle/DNA Damage; Cytoskeleton
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close